Skip to main content

Day: February 10, 2020

Aurora Mobile Releases Report Highlighting Key Mobile Internet Trends Throughout the Coronavirus Outbreak

SHENZHEN, China, Feb. 10, 2020 (GLOBE NEWSWIRE) — Aurora Mobile Limited (“Aurora Mobile” or the “Company”) (NASDAQ:JG), a leading mobile developer service provider in China, today released a report that provides deep insights into key mobile internet trends and usage that have been taking place since the outbreak of the coronavirus began prior to the Chinese New Year holiday (“CNY Holiday”). Leveraging its cutting-edge technology, analytics and ability to quickly analyze cross-industry mobile internet data, Aurora Mobile has been carefully monitoring the usage of apps in real-time throughout the outbreak.As the coronavirus spread during the period before and after the Chinese New Year holiday, the majority people across the country remained at home and avoided outdoor activities which resulted...

Continue reading

II-VI Incorporated Reports Fiscal 2020 Second Quarter Results

First Complete Fiscal Quarter with FinisarRevenue Exceeded Top End of GuidanceQuarterly Revenue of $666.3 million, Exceeded Top End of our Guidance by 6% and the Analysts’ Consensus by 9%, with Strength Across Most MarketsQuarterly GAAP Operating Loss Includes $91 million of One Time Transaction ExpensesQuarterly Adjusted Operating Income Increased 28% SequentiallyContinuing Progress on Integration and Cost Synergy StrategiesPITTSBURGH, Feb. 10, 2020 (GLOBE NEWSWIRE) — II-VI Incorporated (Nasdaq:IIVI) (“II-VI” or the “Company”) today reported results for its fiscal 2020 second quarter ended December 31, 2019.“The just-completed quarter marks the first full quarter of II-VI operations with Finisar included, since the transaction closed on September 24, 2019.  Revenue of $666.3M exceeded...

Continue reading

Varonis Announces Fourth Quarter and Full Year 2019 Financial Results

Annual recurring revenues grew to $210.5 million, a 62% increase over fourth quarter 2018Subscription revenues were 82% of fourth quarter 2019 license revenuesNEW YORK, Feb. 10, 2020 (GLOBE NEWSWIRE) — Varonis Systems, Inc. (Nasdaq: VRNS), a pioneer in data security and analytics, today announced results for the fourth quarter and full year ended December 31, 2019.Yaki Faitelson, Varonis CEO, said, “We completed the year with a strong fourth quarter, as new and existing customers continue to embrace the Varonis Data Security Platform which reduces risk, better detects and responds to insider threats and cyberattacks, and helps to improve regulatory compliance. At the same time, we continued our rapid transition to a subscription model. Over the last twelve months, we believe that we have built the foundation for...

Continue reading

iRhythm Technologies to Report Fourth Quarter and Full Year 2019 Financial Results on February 27, 2020

SAN FRANCISCO, Feb. 10, 2020 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that it will release financial results for the fourth quarter and full year 2019 after the close of trading on Thursday, February 27, 2020.  The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.Investors interested in listening to the conference call may do so by dialing (844) 348-0016 for domestic callers or (213) 358-0876 for international callers, using Conference ID: 5206859. A live and archived webcast of the event will be available on the “Investors” section of the company’s website at: www.irhythmtech.com.About iRhythm Technologies, Inc.iRhythm...

Continue reading

Noodles & Company to Announce Fourth Quarter & Full Year 2019 Results on February 26, 2020

BROOMFIELD, Colo., Feb. 10, 2020 (GLOBE NEWSWIRE) — Noodles & Company (NASDAQ: NDLS) today announced that it will host a conference call to discuss its fourth quarter & full year 2019 financial results on Wednesday, February 26, 2020 at 4:30 p.m. ET. Hosting the call will be Dave Boennighausen, Chief Executive Officer and Ken Kuick, Chief Financial Officer. A press release with fourth quarter & full year 2019 financial results will be issued after the market close that same day.The conference call can be accessed live over the phone by dialing (877) 303-1298 or for international callers by dialing (253) 237-1032. A replay will be available after the call and can be accessed by dialing (855) 859-2056 or for international callers by dialing (404) 537-3406; the passcode is 8982244. The replay will be available until Wednesday,...

Continue reading

Avista announces Marian Durkin to retire in August 2020  

SPOKANE, Wash., Feb. 10, 2020 (GLOBE NEWSWIRE) — Avista announced today that Senior Vice President, Chief Legal Officer and Corporate Secretary Marian Durkin will retire on Aug. 1, 2020. Durkin joined Avista on Aug. 1, 2005 as Senior Vice President and General Counsel. Soon after arriving at Avista, she added responsibilities for Chief Compliance Officer. And in 2016, she became Corporate Secretary.“We want to thank Marian for her 15 years of service to Avista. During her tenure, Marian has defined our business needs to build our Legal Department from the ground up to the robust team it is today. As the focus and scrutiny on compliance has grown across many different industries, Marian has also centralized the company’s compliance efforts and taken our Compliance Department to a new level,” said Avista President...

Continue reading

LogicBio Therapeutics Provides Update on FDA Review of Investigational New Drug Application for LB-001 for Methylmalonic Acidemia

CAMBRIDGE, Mass., Feb. 10, 2020 (GLOBE NEWSWIRE) — LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients, today announced that the U.S. Food and Drug Administration (FDA) has placed a clinical hold on the Investigational New Drug (IND) submission for LB-001 for the treatment of methylmalonic acidemia (MMA) pending the resolution of certain clinical and nonclinical questions. The Company submitted the IND in January 2020 to support the initiation of a Phase 1/2 clinical trial in patients with MMA. LogicBio expects that the FDA questions will be provided in writing within 30 days. LogicBio plans to work closely with the FDA to resolve these questions as quickly as possible.  About LB-001LB-001 is an investigational pediatric...

Continue reading

Can-Fite BioPharma Announces Pricing of $5 Million Public Offering

PETACH TIKVA, Israel, Feb. 10, 2020 (GLOBE NEWSWIRE) — Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today announced the pricing of a public offering of 3,333,334 units at a price to the public of $1.50 per unit. The Company expects to receive aggregate gross proceeds of approximately $5.0 million from the offering, before deducting the placement agent fees and estimated offering expenses. Each unit is comprised of one American Depositary Share (ADS) (or ADS equivalent) and one warrant to purchase one ADS at an exercise price of 1.50 per ADS. The warrants are immediately exercisable upon issuance and have a term of five years. Each ADS represents 30 ordinary shares of the Company. The...

Continue reading

Atari VCS continues its development and acquires the rights to the Wonder technology for cross-platform gaming

Atari VCS continues its development and acquires the rights to the Wonder technology for cross-platform gamingAtari granted exclusive license for the WonderOS mobile gaming platform for 10 yearsAtari can at any time obtain the definitive transfer of ownership of this technologyAtari to integrate WonderOS into the development roadmap of the Atari VCSParis, February 10, 2020 – Atari announces that it has entered into an agreement with Wonder, a mobile technology company, that has been developing the mobile gaming platform WonderOS for the past four years.  WonderOS is an Android-based hybrid mobile gaming platform that turns your smartphone into a console experience with a combination of software and accessories, that allow users to play any kind of game, locally or through the cloud, on a mobile device. As part of the agreement,...

Continue reading

Atari VCS poursuit son développement et acquiert le droit d’utilisation de la technologie Wonder pour les jeux multiplateformes

  Atari VCS poursuit son développement et acquiert le droit d’utilisation de la technologie Wonder pour les jeux multiplateformesAtari obtient une licence exclusive pour la plateforme mobile de jeu WonderOS pour 10 ansAtari peut à tout moment obtenir le transfert définitif de la propriété de cette technologieAtari intégrera WonderOS dans la feuille de route du développement de l’Atari VCSParis, France, le 10 février 2020 – Atari annonce aujourd’hui avoir signé un accord avec Wonder, une société de technologie mobile, qui a développé la plateforme de jeu mobile WonderOS depuis plus de quatre ans. WonderOS est une plateforme hybride de jeu mobile et de divertissement basée sur le système d’exploitation...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.